XML 59 R39.htm IDEA: XBRL DOCUMENT
v3.25.4

Investments - Gross Amounts Not Offset in Statements of Financial Condition (Detail) - USD ($) | Dec. 31, 2025 | Dec. 31, 2024
--- | --- | ---
ProShares Ultra Bloomberg Crude Oil [Member] | Citibank N.A. [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | $ (1,000,501) | $ 7,607,910
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | (6,395,678)
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 1,000,501 | 0
Net Amounts | 0 | 1,212,232
ProShares Ultra Bloomberg Crude Oil [Member] | Goldman Sachs International [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | (4,341,571) | 12,024,863
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | (10,093,437)
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 4,341,571 | 0
Net Amounts | 0 | 1,931,426
ProShares Ultra Bloomberg Crude Oil [Member] | Morgan Stanley & Co. International PLC [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | (1,318,911) | 3,652,992
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 1,318,911 | (3,010,925)
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 0 | 0
Net Amounts | 0 | 642,067
ProShares Ultra Bloomberg Crude Oil [Member] | Societe Generale [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | (3,285,599) | 9,139,394
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | (7,689,268)
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 3,285,599 | 0
Net Amounts | 0 | 1,450,126
ProShares Ultra Bloomberg Crude Oil [Member] | UBS AG [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | (1,204,539) | 5,790,451
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | (4,212,271)
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 1,204,539 | 0
Net Amounts | 0 | 1,578,180
ProShares Ultra Euro [Member] | Goldman Sachs International [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | 31,315 | (84,115)
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | 0
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 0 | 84,115
Net Amounts | 31,315 | 0
ProShares Ultra Euro [Member] | UBS AG [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | 31,375 | (83,013)
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | 0
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 0 | 83,013
Net Amounts | 31,375 | 0
ProShares Ultra Gold [Member] | Citibank N.A. [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | 16,272,555 | (1,008,254)
Financial Instruments for the Benefit of (the Funds) / the Counterparties | (16,272,555) | 1,008,254
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 0 | 0
Net Amounts | 0 | 0
ProShares Ultra Gold [Member] | Goldman Sachs International [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | 2,924,937 | (478,889)
Financial Instruments for the Benefit of (the Funds) / the Counterparties | (2,924,937) | 478,889
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 0 | 0
Net Amounts | 0 | 0
ProShares Ultra Gold [Member] | UBS AG [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | 9,478,963 | (860,989)
Financial Instruments for the Benefit of (the Funds) / the Counterparties | (9,478,963) | 860,989
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 0 | 0
Net Amounts | 0 | 0
ProShares Ultra Silver [Member] | Citibank N.A. [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | 149,280,584 | (23,367,397)
Financial Instruments for the Benefit of (the Funds) / the Counterparties | (149,280,584) | 15,165,751
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 0 | 8,201,646
Net Amounts | 0 | 0
ProShares Ultra Silver [Member] | Goldman Sachs International [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | 10,108,427 | (2,057,658)
Financial Instruments for the Benefit of (the Funds) / the Counterparties | (10,108,427) | 2,057,658
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 0 | 0
Net Amounts | 0 | 0
ProShares Ultra Silver [Member] | Morgan Stanley & Co. International PLC [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | 68,581,771 | (13,960,418)
Financial Instruments for the Benefit of (the Funds) / the Counterparties | (68,581,771) | 0
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 0 | 13,960,418
Net Amounts | 0 | 0
ProShares Ultra Silver [Member] | UBS AG [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | 85,942,476 | (13,133,435)
Financial Instruments for the Benefit of (the Funds) / the Counterparties | (85,942,476) | 13,133,435
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 0 | 0
Net Amounts | 0 | 0
ProShares Ultra Yen [Member] | Goldman Sachs International [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | (582,024) | (2,164,084)
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | 0
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 582,024 | 2,164,084
Net Amounts | 0 | 0
ProShares Ultra Yen [Member] | UBS AG [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | (600,624) | (2,051,213)
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | 0
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 600,624 | 2,051,213
Net Amounts | 0 | 0
ProShares UltraShort Euro [Member] | Goldman Sachs International [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | (202,439) | 584,165
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | (507,449)
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 202,439 | 0
Net Amounts | 0 | 76,716
ProShares UltraShort Euro [Member] | UBS AG [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | (189,935) | 572,885
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | (271,576)
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 189,935 | 0
Net Amounts | 0 | 301,309
ProShares UltraShort Gold [Member] | Citibank N.A. [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | (1,863,184) | 32,589
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | 0
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 1,863,184 | 0
Net Amounts | 0 | 32,589
ProShares UltraShort Gold [Member] | Goldman Sachs International [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | (276,649) | 42,928
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | 0
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 276,649 | 0
Net Amounts | 0 | 42,928
ProShares UltraShort Gold [Member] | UBS AG [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | (428,363) | 66,064
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | 0
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 428,363 | 0
Net Amounts | 0 | 66,064
ProShares UltraShort Silver [Member] | Citibank N.A. [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | (1,454,002) | 1,653,589
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | (1,565,508)
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 1,454,002 | 0
Net Amounts | 0 | 88,081
ProShares UltraShort Silver [Member] | Goldman Sachs International [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | (4,490,093) | 907,867
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | (865,802)
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 4,490,093 | 0
Net Amounts | 0 | 42,065
ProShares UltraShort Silver [Member] | Morgan Stanley & Co. International PLC [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | (619,454) | 125,172
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | 0
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 619,454 | 0
Net Amounts | 0 | 125,172
ProShares UltraShort Silver [Member] | UBS AG [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | 2,243,402 | 267,390
Financial Instruments for the Benefit of (the Funds) / the Counterparties | 0 | 0
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 0 | 0
Net Amounts | 2,243,402 | 267,390
ProShares UltraShort Yen [Member] | Goldman Sachs International [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | 435,346 | 1,253,912
Financial Instruments for the Benefit of (the Funds) / the Counterparties | (281,679) | (1,241,201)
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 0 | 0
Net Amounts | 153,667 | 12,711
ProShares UltraShort Yen [Member] | UBS AG [Member] |  |
Cash Collateral for the Benefit of (the Funds) / the Counterparties |  |
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition | 408,889 | 974,447
Financial Instruments for the Benefit of (the Funds) / the Counterparties | (302,661) | (954,822)
Cash Collateral for the Benefit of (the Funds) / the Counterparties | 0 | 0
Net Amounts | $ 106,228 | $ 19,625

X
- Definition Fair value, after effects of master netting arrangements, deduction of assets (liabilities) not subject to a master netting arrangement and elected not to be offset, of financial asset or other contract (liability or contract) with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against an obligation to return collateral. + References No definition available. + Details
Name: | agq_DerivativeAssetLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
Namespace Prefix: | agq_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of financial asset or other contract (liability or other contract) with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, not subject to a master netting arrangement, deducted from derivative assets. + References No definition available. + Details
Name: | agq_DerivativeAssetsLiabilitiesNotSubjectToMasterNettingArrangementDeduction
Namespace Prefix: | agq_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of obligation to return cash collateral (right to receive cash collateral) under master netting arrangements that have not been offset against derivative assets. + References No definition available. + Details
Name: | agq_DerivativeCollateralObligationToReturnCashRightToReclaimCash
Namespace Prefix: | agq_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 20 -Name Accounting Standards Codification -Section 25 -Paragraph 6A -Publisher FASB -URI https://asc.fasb.org/1943274/2147480682/815-20-25-6A Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5 + Details
Name: | us-gaap_DerivativeLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=agq_ProsharesUltraBloombergCrudeOilMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=agq_CitibankNaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=agq_GoldmanSachsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=agq_MorganStanleyAndCoInternationalPlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=agq_SocieteGeneraleSaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=agq_UbsAgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=agq_ProsharesUltraEuroMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=agq_ProsharesUltraGoldMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=agq_ProsharesUltraSilverMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=agq_ProsharesUltraYenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=agq_ProsharesUltraShortEuroMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=agq_ProsharesUltraShortGoldMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=agq_ProsharesUltraShortSilverMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=agq_ProsharesUltraShortYenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |